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Abstract Histidine decarboxylase (HDC) synthesizes histamine
from histidine in mammals. To evaluate the role of histamine, we
generated HDC-deficient mice using a gene targeting method.
The mice showed a histamine deficiency and lacked histamine-
synthesizing activity from histidine. These HDC-deficient mice
are viable and fertile but exhibit a decrease in the numbers of
mast cells while the remaining mast cells show an altered
morphology and reduced granular content. The amounts of mast
cell granular proteases were tremendously reduced. The HDC-
deficient mice provide a unique and promising model for studying
the role of histamine in a broad range of normal and disease
processes. ß 2001 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Histamine is synthesized by a unique enzymatic reaction
with L-histidine decarboxylase (HDC). In the pathological
skin condition, histamine is involved in the induction of itch-
ing, £aring and edema [1,2]. In addition, various studies have
suggested a close relationship between wound healing [3], em-
bryogenesis [4], hematopoiesis [5] and malignant growth [6,7]
with histamine production. From these points, establishing
knockout mice with defective histamine synthesis was thought
to be important, and therefore, we introduced a mutation into
the HDC gene that resulted in mice without HDC activity.
The biological role of histamine has been extensively
studied with pharmacological approaches using speci¢c recep-
tor agonists and antagonists [8] or using histamine synthesis
inhibitors [9]. Due to the overlapping and sometimes antago-
nistic function of the receptors in the presence of endogenous
histamine, receptor-blocking alone cannot achieve complete
elimination of the histamine system. And also, histamine re-
ceptors might cryptically bind to substances other than hista-
mine. Although the histamine synthesis blocker K-£uorometh-
yl histidine (K-FMH) signi¢cantly decreases the level of
histamine in various organs, it is di⁄cult to achieve complete
and long lasting elimination of histamine in vivo in this man-
ner. Therefore, we concentrated on the elimination of hista-
mine biosynthesis by an ES cell-mediated gene targeting ap-
proach.
2. Materials and methods
2.1. Generation of HDC gene knockout mice
We designed the HDC targeting construct to replace a V2.4 kb
fragment extending from intron 5 to exon 9 with a PGK promoter-
neor cassette. PCR positive ES clones were con¢rmed for proper ho-
mologous recombination by Southern blot in two steps. First we
checked whether there was a homologous recombination-based inser-
tion at the 3P homology arm in the candidate cell lines by using PstI-
digested and EcoRI-digested DNA and the BamHI^StuI internal
probe to get a 6.5 kb and an 11 kb band as shown in Fig. 1A.
Then we showed the loss of the wild type StuI band in animals ho-
mozygous for the targeted allele (Fig. 1B).
2.2. Northern blot, HDC activity and histamine analysis
20 Wg of the RNA extracted from the kidney was examined by
Northern blot analysis using HDC cDNA as a probe. The low hista-
mine (0.6 nmol/g diet) containing diets (L) were purchased from a
commercial source (Nihon Nosan Kogyo K.K., Yokohama, Japan).
The histamine content and HDC activity of the organs were measured
essentially by the method as described in [10]. Brie£y, for the hista-
mine assay, organs were homogenized in 10 volumes of 3% perchloric
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acid containing 5 mM sodium EDTA by a Polytron homogenizer
(Kinematica, Lucern, Switzerland) and centrifuged at 10 000Ug for
30 min at 4‡C. An aliquot of 50 Wl of the supernatant was injected
into the high performance liquid chromatography system in which
histamine was separated on a cation-exchanger TSK SP-2SW (6 mm
inside diameterU15 cm, Toso, Tokyo, Japan) column and automati-
cally mixed with o-phthalaldehyde in alkaline conditions. Fluores-
cence was measured with a £uoromonitor (L-7480, Hitachi, Tokyo,
Japan) using excitation and emission wavelengths of 360 and 450 nm,
respectively. The HDC activity was expressed as the amount of his-
tamine synthesized from histidine per min per mg of protein. Protein
was measured with the Protein Assay system (Bio-Rad, Tokyo,
Japan).
2.3. Light and electron microscopy of mast cells
Bone marrow-derived mast cells (BMMCs) were prepared as de-
scribed by Razin et al. [11] with minor modi¢cations. The bone mar-
row cells were cultured at a concentration of 0.5^1U106 nucleated
cells/ml in RPMI 1640 (Life Technologies, Tokyo, Japan) supple-
mented with 10% fetal calf serum (ICN Biomedicals, Aurora, OH.
USA), 5 ng/ml interleukin-3 (RpD systems, Minneapolis, MN,
USA), 100 IU/ml penicillin and 100 Wg/ml streptomycin. Non-adher-
ent cells were transferred to fresh BMMC medium at least once a
week. After 10 weeks, BMMCs were stained with toluidine blue.
For the peritoneal cell staining, 5 ml phosphate-bu¡ered saline was
injected into the peritoneal cavity and after slight massage it was
collected and stained using the alcian^safranin method [12]. Tissues
for electron microscopy were ¢xed in Karnovsky’s and embedded in
epoxy resin and analyzed using an electron microscope.
2.4. Reverse transcriptase (RT)-PCR
The cDNA prepared from peritoneal cell suspension via RNA was
serially diluted in a 10-fold fashion and ampli¢ed with PCR. PCR was
carried out with speci¢c sets of primers. The primers used in PCR
were as follows (5P to 3P) : mouse mast cell protease (MMCP)-4, GTG
TTG AGT CTA GAC CAC ATT CTC G and ACA GGC CTC TTT
ATC CAT GAT TCT C; MMCP-5, CCT GGG TTC CAG CAC
CAA AG and TGG ACA ACC AAA TTC TCA TC; mast cell
carboxypeptidase A (MC-CPA), TAT GAC TGT GGA TTT CCG
AG and TAT AAT GGA TCT TCA AC; glycerol 3-phosphate de-
hydrogenase, GGT GCT GAG TAT GTC GTG GA and TGG TCC
TCA GTG TAG CCC AA.
2.5. Western blot analysis
Peritoneal cells were solubilized in 50 Wl of SDS^PAGE electropho-
resis sample bu¡er/1U106 cells. These extracts were subjected to
SDS^PAGE. The antiserum to MMCP-4 was produced in rabbits,
whereas antisera to MMCP-5 and MC-CPA were produced in rats
[13]. The second antibodies were either goat anti-rabbit Ig (Amer-
sham) or goat anti-rat Ig (Sigma) conjugated to horseradish peroxi-
dase. The ¢lters were developed with the ECL system (Amersham)
according to the protocol provided by the manufacturer.
3. Results
3.1. Creating a null allele of the HDC gene
The murine HDC gene contains 12 exons and spans 23 kb
of genomic DNA [14]. Using gene targeting, we replaced in-
tron 5 to exon 9 with an inverted PGK promoter-driven neo-
mycin phosphotransferase (neo) gene (Fig. 1A). This replace-
ment resulted in a null mutation since exon 8 contains the
coding sequence for the putative binding site (TFNPSKW)
to which pyridoxal 5P-phosphate, the coenzyme of HDC pro-
tein, is supposed to bind [15]. We analyzed the genotypes of
180 pups (Fig. 1B) from intercrosses between heterozygous
mice, which showed the expected Mendelian heredity (28.9%
wild type, 49.4% heterozygous, 21.7% homozygous), suggest-
ing that HDC is not crucial for embryonic development. In
addition to the homozygous viability, successive intercrosses
suggested normal fertility. Using Northern blot analysis, we
could not detect the expression of the HDC gene from the
targeted allele (Fig. 1C). Therefore, we concluded that a null
allele had been created.
3.2. Histamine levels and histamine synthesis in the
HDC-de¢cient animals
The histamine levels and the histamine synthesis activity
were measured in various organs of HDCv6ÿ8/HDCv6ÿ8 mice
under low histamine diet (L) conditions (Table 1). The tissues
of the HDCv6ÿ8/HDCv6ÿ8 animals lacked the histamine syn-
thesis activity. The tissue histamine levels of various organs
were practically zero except for that of brain.
3.3. Mast cell histology and biochemistry
The mast cell numbers in 13 randomly chosen microscope
¢elds in mesenterial membrane preparations were evaluated.
Wild type mice had 94 þ 11 cells/¢eld, whereas HDCv6ÿ8/
HDCv6ÿ8 mice had 32.9 þ 7.1 cells/¢eld, representing a signi¢-
cant decrease of 65%. In the BMMC preparation, mast cells
of HDCv6ÿ8/HDCv6ÿ8 mice showed pale and sparse granules
compared to those of the wild type mice with toluidine blue
staining (Fig. 2A,B). The number of the mast cells determined
by safranin staining was reduced in the HDCv6ÿ8/HDCv6ÿ8
mice peritoneal cell suspension (Fig. 2C,D). Electron micros-
copy (Fig. 2E^H) revealed further details of the reduced gran-
Fig. 1. Generation of a targeted mutation in HDC gene. A: Target-
ing strategy for removal of exons 6^8. The exons are indicated by
black boxes. The probe used for Southern blotting analysis of the
3P arm recombination is shown as a shaded bar and the diagnostic
restriction fragments with their expected sizes as lines. B, BamHI;
E, EcoRI; P, PstI; St, StuI. B: The three genotypes are represented
in the F2 generation. C: Northern blot analysis using the HDC
probe, revealing a predominant 2.7 kb fragment in the kidney of
HDC= and HDC=/HDCv6ÿ8 mice but not in HDCv6ÿ8/
HDCv6ÿ8 mice.
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ular contents. The mast cells of HDCv6ÿ8/HDCv6ÿ8 mice were
very heterogeneous in terms of staining strength of their gran-
ule. Some mast cells possessed fairly empty granules (Fig. 2F);
on the other hand some other mast cells possessed granules
with smaller granular contents inside them (Fig. 2H). The
total number of secretory granules per mast cell of
HDCv6ÿ8/HDCv6ÿ8 mice seemed to be similar to that of
wild type mice.
The reduced granular content of the mast cells was very
interesting since histamine is not the major component of
the mast cell granules. Because the reduction in the contents
of the granules may re£ect reduced granular protease, we
assessed the mast cell proteases in terms of their mRNA ex-
pression and protein level using RT-PCR analysis and West-
ern blotting, respectively. The amount of MMCP-4, MMCP-5
and MC-CPA was decreased in HDCv6ÿ8/HDCv6ÿ8 mice in
Western blotting (Fig. 3B), whereas the RNA expression level
seemed to be not so a¡ected (Fig. 3A). Histamine therefore
might be one of the important mediators for maintaining
proteases in the mast cell secretory granules or it might a¡ect
Table 1
Histamine content (H) and HDC activity (HDC) in organs of animals segregating a HDC null allele
Organ Genotype HDC/HDC HDC/HDCv6ÿ8 HDCv6ÿ8/HDCv6ÿ8
Plasma H 0.32 þ 0.06 0.13 þ 0.01 0.04 þ 0.01
Skin H 21.22 þ 4.25 19.21 þ 0.29 0.26 þ 0.06
HDC 2.12 þ 0.56 0.60 þ 0.08 0.00 þ 0.05
Brain *H 58.67 þ 9.83 31.61 þ 5.15 18.41 þ 2.74
HDC 0.24 þ 0.04 0.12 þ 0.01 0.00 þ 0.00
Stomach H 4.36 þ 0.50 2.76 þ 0.22 0.10 þ 0.05
HDC 1.98 þ 0.22 1.23 þ 0.32 0.03 þ 0.02
Spleen H 0.94 þ 0.52 0.19 þ 0.04 0.04 þ 0.01
HDC 0.01 þ 0.00 0.01 þ 0.00 0.01 þ 0.00
Kidney H 2.11 þ 1.28 1.07 þ 0.12 0.01 þ 0.00
HDC 18.03 þ 0.01 13.13 þ 1.44 0.01 þ 0.00
Histamine levels are given in: *pmol/g tissue for brain, nmol/g tissue for skin, stomach, spleen and kidney and nmol/ml for plasma. HDC con-
centrations are given in pmol/mg protein/min (mean þ S.E.M., n = 4).
Fig. 2. A,B: BMMC preparation from wild type (A) or HDCv6ÿ8/
HDCv6ÿ8 (B) mice stained with toluidine blue. C,D: Peritoneal cell
suspension from wild type (C) or HDCv6ÿ8/HDCv6ÿ8 (D) mice
stained with alcian blue and counter-stained with safranin O. Trans-
mission electron microscopy of mast cells from the peritoneum
(E,F), from the skin of the back (G,H) of wild type (E,G) and
HDCv6ÿ8/HDCv6ÿ8 (F,H) mice.
Fig. 3. The protease expression in peritoneal cells. A: RNA expres-
sion was analyzed using RT-PCR. Each PCR ampli¢cation set from
one animal was comprised of four serially 10-fold dilutions of
cDNA as the template and assessed on 2% agarose gel. B: Western
blotting was carried out for the assessment of protease at the pro-
tein level. The extracts from 5U105 cells were subjected to SDS^
PAGE.
FEBS 25074 23-7-01 Cyaan Magenta Geel Zwart
H. Ohtsu et al./FEBS Letters 502 (2001) 53^56 55
the synthesis of these proteases. Further study is needed to
explain the underlying mechanism.
4. Discussion
HDC is the unique enzyme that produces histamine. Gene
targeting of the HDC gene was performed to create histamine-
de¢cient mice. The targeting vector used in this study was
designed to replace exons 6^8 and part of exon 9 of the
HDC gene with an inverted neo selectable marker. We anticip-
ated that, even if a truncated protein were produced from the
targeted locus, this alteration would remove the putative bind-
ing site of pyridoxal 5P-phosphate, an essential coenzyme for
HDC activity [15], and, therefore, would render the protein
non-functional. Interestingly, however, the inverted neo select-
able marker abolished the HDC gene expression at the tran-
scriptional level. This ¢nding further supports our previous
observation that the inverted neo marker has an e⁄cient tran-
scriptional knockdown e¡ect on a targeted allele [16].
HDCv6ÿ8/HDCv6ÿ8 mice lack histamine-synthesizing activ-
ity from histidine and basically lack histamine in several or-
gans. Although the results of human genomic DNA blot hy-
bridization analysis strongly suggested that HDC is speci¢ed
by a single gene [17], because a certain amount of histamine
was detected in the brain of HDCv6ÿ8/HDCv6ÿ8 mice, there is
still a possibility that, in brain, there is another enzyme cata-
lyzing histamine production. Blocking the endogenous pro-
duction of histamine does not necessarily create a histamine
de¢ciency, as dietary histamine intake can be an alternative
source. Therefore, in the experiments described we decided to
control for the dietary histamine uptake by supplementing the
histamine-de¢cient diet with a de¢ned amount of histamine.
Tissue histamine is localized in the specialized membrane-
enclosed secretory granules of mast cells. The granules, which
account for V50% of the total mast cell volume, are com-
prised primarily of heparin and basic proteins. Although the
nature of the mechanism by which histamine is stored in
granules has not been established, there is evidence suggesting
that heparin provides the histamine binding sites [18,19]. The
reduced granulation phenotype of mast cells in the case of
histamine de¢ciency is interesting since histamine is not the
major component of the mast cell granules. Because the sub-
cutaneous and peritoneal mast cells of HDCv6ÿ8/HDCv6ÿ8
mice stained weakly with safranin, they appeared to contain
less heparin in the granules. Possibly, the lack of histamine
could disturb the normal electrostatic balance between the
positively charged histamine molecules and the negatively
charged heparin proteoglycan in such a way that heparin
storage is impaired. It is noteworthy that the lack of heparin
by gene disruption results in a similar phenotype in the secre-
tory granules, with a large reduction in the overall contents of
secretory granule components, including histamine and pro-
teases [13,20]. The present ¢ndings thus indicate that also the
lack of histamine could result in a general reduction in the
secretory granule contents. Further evidence for this was ob-
tained when the contents of mast cell proteases were analyzed
at the protein level by Western blotting. These experiments
demonstrated a large reduction of the mast cell proteases
MMCP-4, MMCP-5 and CPA in the HDCv6ÿ8/HDCv6ÿ8
mice. Since all of these proteases have high positive net
charges, their reduction in the HDCv6ÿ8/HDCv6ÿ8 mice could
be an e¡ect of a possible overall disturbed electrostatic bal-
ance in the granules, e.g. a reduction in balancing negatively
charged heparin proteoglycan to interact with.
For revealing the role of histamine, earlier attempts in-
volved the injection of HDC blockers such as K-FMH into
animals. Even though K-FMH signi¢cantly decreased the level
of histamine in various organs, it was di⁄cult to achieve com-
plete and long lasting elimination of histamine in vivo. Here
we demonstrated that the targeted deletion of the HDC gene
provides a unique in vivo model of histamine de¢ciency. Stud-
ies using HDCv6ÿ8/HDCv6ÿ8 mice will enable a detailed
understanding of the role of histamine in various physiolog-
ical and pathological processes.
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